Data / Form D filings / Spine BioPharma, Inc.
Spine BioPharma, Inc.: Form D filings
Spine BioPharma, Inc., a pharmaceuticals company in New York, NY, filed 8 Form D notices with the SEC between 2021 and 2026. The latest, on June 5, 2026, reports $384,798 sold of a $8.5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 505 PARK AVENUE, 14TH FLOOR, New York, NY, 10022
- Phone
- (212) 583-9700
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1852647
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | New notice | $8,500,000 | $384,798 | $8,115,202 | 3 | May 22, 2026 | sec.gov |
| Dec 18, 2024 | New notice | $23,500,000 | $13,505,000 | $9,995,000 | 10 | Sep 9, 2024 | sec.gov |
| Oct 11, 2023 | New notice | $15,000,000 | $2,399,629 | $12,600,371 | 3 | Oct 4, 2023 | sec.gov |
| Aug 31, 2023 | New notice | $13,000,000 | $1,900,000 | $11,100,000 | 1 | Aug 24, 2023 | sec.gov |
| Feb 8, 2023 | New notice | $13,000,000 | $13,000,000 | 8 | Feb 3, 2023 | sec.gov | |
| Mar 24, 2022 | New notice | $30,350,000 | $12,999,991 | $17,350,009 | 6 | Mar 17, 2022 | sec.gov |
| Apr 20, 2021 | New notice | $3,000,000 | $3,000,000 | 1 | Apr 16, 2021 | sec.gov | |
| Mar 22, 2021 | New notice | $5,000,515 | $5,000,515 | 14 | Mar 12, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marc R. Viscogliosi | Executive Officer, Director | Director and Chief Executive Officer of the Issuer |
| Fran Magee | Executive Officer | Chief Technology Officer |
| Thomas Bumol, PhD | Director | |
| Frank Cammisa, MD | Director | |
| John J. Viscogliosi | Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Jun 1, 2026 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Spine BioPharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.